What It Is: Billed as a competitor to Botox, this neurotoxin is currently only used for treatment of cervical dystonia. It briefly hit the injectables market last year, but was removed and banned from being used for facial aesthetic purposes after a lawsuit filed by Allergan, the makers of Botox, found that Merz, the makers of Xeomin violated the California Trade Secrets Act. Oh, pharmaceutical companies. Can't we all just get along?
Who It's For: When it finally does resurface, this treatment will be a good option for those wishing to reduce fine lines, crow's feet, frown lines, and smoker's lines. According to Dr. Colbert, it will also help rid the neck of ropiness and can create a lifted effect on the eye and brow.
What To Expect: Since it shares the same active ingredient as Botox — botulinium toxin A, Xeomin will presumably work the same way, relaxing the muscles at the site of injection to smooth out lines. It will also, purportedly, have the same side effects as Botox, including some redness, bleeding, bruising, and swelling at the injection site. According to Dr. Colbert, it will also take about a week or two for results to fully take effect.
Photo: Robert Daly